Wenqun Li

2.0k total citations · 1 hit paper
58 papers, 1.5k citations indexed

About

Wenqun Li is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Wenqun Li has authored 58 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 18 papers in Cardiology and Cardiovascular Medicine and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Wenqun Li's work include Chemotherapy-induced cardiotoxicity and mitigation (15 papers), MicroRNA in disease regulation (6 papers) and Inflammasome and immune disorders (6 papers). Wenqun Li is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (15 papers), MicroRNA in disease regulation (6 papers) and Inflammasome and immune disorders (6 papers). Wenqun Li collaborates with scholars based in China and Poland. Wenqun Li's co-authors include Bikui Zhang, Shanshan Wei, Wanjun Ma, Taoli Sun, Weijun Peng, Chuanhao Jiang, Jiaqin Liu, Yuan‐Jian Li, Xiaohui Li and Daxiong Xiang and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Biochemical Pharmacology.

In The Last Decade

Wenqun Li

57 papers receiving 1.5k citations

Hit Papers

Network Pharmacology Pred... 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis
    2021 164 citations Jiaqin Liu, Jian Liu et al. Drug Design Development and Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenqun Li China 22 712 272 176 166 163 58 1.5k
Xi Chu China 26 844 1.2× 284 1.0× 247 1.4× 167 1.0× 149 0.9× 98 2.0k
Weixing Shen China 24 865 1.2× 190 0.7× 168 1.0× 140 0.8× 207 1.3× 94 1.7k
Shanshan Wei China 16 605 0.8× 236 0.9× 218 1.2× 88 0.5× 96 0.6× 51 1.3k
Cecilia Hsuan Day Taiwan 24 786 1.1× 165 0.6× 118 0.7× 78 0.5× 183 1.1× 75 1.7k
Yangyang Hu China 20 869 1.2× 171 0.6× 142 0.8× 134 0.8× 216 1.3× 53 2.1k
Guozhen Cui China 23 721 1.0× 136 0.5× 149 0.8× 104 0.6× 137 0.8× 85 1.5k
Hai‐Han Liao China 23 666 0.9× 434 1.6× 99 0.6× 102 0.6× 128 0.8× 42 1.4k
Yuanyuan Cheng China 25 986 1.4× 159 0.6× 149 0.8× 97 0.6× 164 1.0× 113 1.9k
Jianchang Qian China 23 719 1.0× 159 0.6× 222 1.3× 105 0.6× 150 0.9× 62 1.5k
Ming‐Yi Shen Taiwan 26 537 0.8× 253 0.9× 129 0.7× 97 0.6× 159 1.0× 80 2.0k

Countries citing papers authored by Wenqun Li

Since Specialization
Citations

This map shows the geographic impact of Wenqun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenqun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenqun Li more than expected).

Fields of papers citing papers by Wenqun Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenqun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenqun Li. The network helps show where Wenqun Li may publish in the future.

Co-authorship network of co-authors of Wenqun Li

This figure shows the co-authorship network connecting the top 25 collaborators of Wenqun Li. A scholar is included among the top collaborators of Wenqun Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenqun Li. Wenqun Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Juan, Xiaofeng Lu, Shan Lu, et al.. (2025). Mitigating Doxorubicin‐Induced Cardiotoxicity and Enhancing Anti‐Tumor Efficacy with a Metformin‐Integrated Self‐Assembled Nanomedicine. Advanced Science. 12(17). e2415227–e2415227. 8 indexed citations
2.
Huang, Jie, Xingyuan Hou, Ni Zhou, et al.. (2025). Novel Protective Role for Gut Microbiota-derived Metabolite PAGln in Doxorubicin-induced Cardiotoxicity. Cardiovascular Drugs and Therapy. 40(1). 65–80. 3 indexed citations
3.
Wei, Shanshan, et al.. (2024). Parthenolide alleviates doxorubicin-induced cardiotoxicity via regulation of Cyp1a1 and Nppa and suppression of NLRP3 inflammasome. Journal of Traditional and Complementary Medicine. 15(7). 726–735.
4.
Liu, Sa, et al.. (2024). Role for the F-box proteins in heart diseases. Pharmacological Research. 210. 107514–107514. 1 indexed citations
5.
Li, Xiangyun, Shanshan Wei, Sa Liu, et al.. (2024). Trillin Protects Against Bleomycin-Induced Pulmonary Fibrosis via Suppressing Oxidative Stress and IL-1β/NLRP3 Inflammasome Positive Cycle. Natural Product Communications. 19(3). 2 indexed citations
6.
Zhou, Ni, Nan Su, Shanshan Wei, et al.. (2024). Noncoding RNA-associated competing endogenous RNA networks in trastuzumab-induced cardiotoxicity. Non-coding RNA Research. 9(3). 744–758. 3 indexed citations
7.
Zhou, Ni, Shanshan Wei, Taoli Sun, et al.. (2023). Recent progress in the role of endogenous metal ions in doxorubicin-induced cardiotoxicity. Frontiers in Pharmacology. 14. 1292088–1292088. 8 indexed citations
8.
Hou, Zhenyan, Miao Yan, Huixiang Li, et al.. (2023). Variable p53/Nrf2 crosstalk contributes to triptolide-induced hepatotoxic process. Toxicology Letters. 379. 67–75. 4 indexed citations
9.
Wei, Shanshan, et al.. (2023). Hyperoside Protects Trastuzumab-Induced Cardiotoxicity via Activating the PI3K/Akt Signaling Pathway. Cardiovascular Drugs and Therapy. 39(3). 481–490. 4 indexed citations
10.
Xiao, Zijun, Shanshan Wei, Jie Huang, et al.. (2022). Noncoding RNA-Associated Competing Endogenous RNA Networks in Doxorubicin-Induced Cardiotoxicity. DNA and Cell Biology. 41(7). 657–670. 4 indexed citations
11.
Liu, Jiaqin, Jian Liu, Xiaoliang Tong, et al.. (2021). Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis. Drug Design Development and Therapy. Volume 15. 3255–3276. 164 indexed citations breakdown →
12.
Li, Wenqun, Jiaqin Liu, Wei Tan, & Yedi Zhou. (2021). The role and mechanisms of Microglia in Neuromyelitis Optica Spectrum Disorders. International Journal of Medical Sciences. 18(14). 3059–3065. 14 indexed citations
13.
Wei, Shanshan, et al.. (2021). Recent Progress in Environmental Toxins-Induced Cardiotoxicity and Protective Potential of Natural Products. Frontiers in Pharmacology. 12. 699193–699193. 18 indexed citations
14.
Li, Da, Taoli Sun, Jian Liu, et al.. (2021). Bai-He-Gu-Jin-Tang formula suppresses lung cancer via AKT/GSK3β/β-catenin and induces autophagy via the AMPK/mTORC1/ULK1 signaling pathway. Journal of Cancer. 12(21). 6576–6587. 6 indexed citations
15.
Wei, Shanshan, Wanjun Ma, Xiaohui Li, et al.. (2020). Involvement of ROS/NLRP3 Inflammasome Signaling Pathway in Doxorubicin-Induced Cardiotoxicity. Cardiovascular Toxicology. 20(5). 507–519. 113 indexed citations
16.
Zou, Yang, Rong Li, Meiling Zuo, et al.. (2020). Galangin Inhibits Cholangiocarcinoma Cell Growth and Metastasis through Downregulation of MicroRNA‐21 Expression. BioMed Research International. 2020(1). 5846938–5846938. 20 indexed citations
17.
Jiang, Chuanhao, Ning Xie, Taoli Sun, et al.. (2020). <p>Xanthohumol Inhibits TGF-β1-Induced Cardiac Fibroblasts Activation via Mediating PTEN/Akt/mTOR Signaling Pathway</p>. Drug Design Development and Therapy. Volume 14. 5431–5439. 77 indexed citations
18.
Chen, Ying, Shanshan Wei, Yao Li, et al.. (2019). Identification and analysis of components in Shen-Fu-Shu granule extract and in rat plasma after oral administration by UPLC-ESI/Q-TOF-MS. Journal of Pharmaceutical and Biomedical Analysis. 169. 159–169. 15 indexed citations
19.
Wei, Shanshan, Taoli Sun, Jie Du, et al.. (2018). Xanthohumol, a prenylated flavonoid from Hops, exerts anticancer effects against gastric cancer in�vitro. Oncology Reports. 40(6). 3213–3222. 72 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xi Chu Breakdown of academic impact, for papers by Weixing Shen Breakdown of academic impact, for papers by Shanshan Wei Breakdown of academic impact, for papers by Cecilia Hsuan Day Breakdown of academic impact, for papers by Yangyang Hu Breakdown of academic impact, for papers by Guozhen Cui Breakdown of academic impact, for papers by Hai‐Han Liao Breakdown of academic impact, for papers by Yuanyuan Cheng Breakdown of academic impact, for papers by Jianchang Qian Breakdown of academic impact, for papers by Ming‐Yi Shen
Rankless by CCL
2026